PRESS RELEASE published on 02/09/2024 at 14:36, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.86% ownership of Barratt Developments plc's relevant securities in a Form 8.3. Public disclosure includes 47,379,144 10p ordinary shares The Vanguard Group, Inc. Form 8.3 Relevant Securities Ownership Disclosure Barratt Developments Plc
PRESS RELEASE published on 02/08/2024 at 15:20, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses a 4.86% interest in Barratt Developments plc. Further disclosures are made for Redrow plc. No supplemental forms attached The Vanguard Group, Inc. Disclosure Redrow Plc Barratt Developments Plc Supplemental Forms
Published on 09/12/2026 at 02:35, 1 day 20 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 1 hour ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 6 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 5 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 15 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days 1 hour ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days 1 hour ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 3 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 3 hours ago Availability of the 2026 Interim Financial Report
